Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1990. Upgrade now.
Date Value
September 30, 2024 9.796B
June 30, 2024 9.809B
March 31, 2024 10.52B
December 31, 2023 10.84B
September 30, 2023 9.914B
June 30, 2023 8.928B
March 31, 2023 8.960B
December 31, 2022 7.742B
September 30, 2022 7.022B
June 30, 2022 7.566B
March 31, 2022 7.051B
December 31, 2021 5.695B
September 30, 2021 5.788B
June 30, 2021 3.911B
March 31, 2021 3.504B
December 31, 2020 3.587B
September 30, 2020 3.026B
June 30, 2020 3.144B
March 31, 2020 4.003B
December 31, 2019 3.214B
September 30, 2019 2.878B
June 30, 2019 2.670B
March 31, 2019 3.232B
December 31, 2018 2.810B
September 30, 2018 2.192B
Date Value
June 30, 2018 1.684B
March 31, 2018 1.625B
December 31, 2017 1.410B
September 30, 2017 1.379B
June 30, 2017 1.268B
March 31, 2017 1.307B
December 31, 2016 1.039B
September 30, 2016 1.408B
June 30, 2016 1.045B
March 31, 2016 849.18M
December 31, 2015 1.045B
September 30, 2015 895.64M
June 30, 2015 604.25M
March 31, 2015 742.16M
December 31, 2014 900.48M
September 30, 2014 1.042B
June 30, 2014 816.91M
March 31, 2014 648.13M
December 31, 2013 693.98M
September 30, 2013 445.32M
June 30, 2013 537.51M
March 31, 2013 307.71M
December 31, 2012 308.10M
September 30, 2012 262.55M
June 30, 2012 301.02M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

3.026B
Minimum
Sep 2020
10.84B
Maximum
Dec 2023
6.701B
Average
7.036B
Median

Cash and Short Term Investments (Quarterly) Benchmarks

Amgen Inc 9.011B
Eli Lilly and Co 3.518B
Pfizer Inc 9.952B
AbbVie Inc 7.285B
Biogen Inc 1.699B